; or (v) completion of an accredited residency or fellowship in addiction medicine or addiction psychiatry. (d) Quality and other reporting requirements (1) Adoption and development of standards and performance measures Not later than 9 months after the date of the enactment of this section, the Secretary, in conjunction with stakeholders (including clinicians in the primary care community and the field of addiction medicine), shall adopt or develop (or an appropriate entity with which the Secretary contracts shall develop) quality standards and methods of assessing the quality of care to ensure a minimum level of quality of care and to determine whether the services furnished by participating care teams are achieving the purposes described in subsection (b)(1). For purposes of adopting or developing standards for payments under subsection (f)(1) and for purposes of adopting or developing methods for assessing performance for the incentive payments under subsection (f)(2), the Secretary may consider existing clinical guidelines for the treatment of opioid use disorders and standards or measures applied for use under the Medicaid program under title XIX. Standards and assessment methods shall address the following outcomes and performance criteria: (A) Patient engagement in treatment. (B) Retention in treatment. (C) Provision of evidence-based medication-assisted treatment. (D) Any other criteria the Secretary deems appropriate. (2) Submission Each participating care team shall submit to the Secretary, in such form, manner, and frequency specified by the Secretary, data with respect to such standards and assessment methods and such other information as the Secretary determines appropriate to monitor and evaluate the Program and to determine the performance of such team for purposes of the incentive payment under subsection (f)(2). (e) Participation of applicable beneficiaries (1) Applicable beneficiary defined In this section, the term applicable beneficiary means an individual who— (A) is entitled to benefits